Status | Study |
Completed |
Study Name: Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease Condition: Retinopathy of Prematurity Date: 2014-05-22 Interventions: Drug: intravitreal injection of 0.03ml ranibizumab |
Completed |
Study Name: A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2011-04-01 |
Completed |
Study Name: Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study Condition: Retinopathy of Prematurity Date: 2010-11-08 Interventions: Drug: propranolol 2 mg per kg |
Withdrawn |
Study Name: Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP) Condition: Retinopathy of Prematurity Date: 2010-10-26 Interventions: Drug: Bevacizumab A single dosage of: 0.625mg(0.025cc)or 0.75mg(0.03cc) will be given intravitreally. |
Completed |
Study Name: Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2010-03-02 Interventions: Drug: Propranolol Dosage of 0.5mg/Kg oral, every 6 hours. |
Completed |
Study Name: Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening Condition: Retinopathy of Prematurity Date: 2009-06-10 Interventions: Other: Sucrose 0.2 ml sucrose |
Terminated |
Study Name: Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2008-06-19 Interventions: Drug: Bevacizumab Dosage of 0.75mg/0.03ml injectable, one time only. |
Completed |
Study Name: Pain Response During Examination for Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2008-03-14 Interventions: Behavioral: suck 12.5% dextrose in water 5 minutes before the procedure Newborns will suck 2 ml of D12.5 |
Enrolling by invitation |
Study Name: Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome Condition: Retinopathy of Prematurity Date: 2006-06-29 Interventions: Drug: intravitreal injection |
Not yet recruiting |
Study Name: Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2006-06-19 Interventions: Drug: erythropoietin and early iron supplements |